[Comparative evaluation of the immunological activity of new typhoid vaccines with established prophylactic effectiveness (data from a controlled experiment)]. 1975

I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov

The authors present the results of studying the immunological efficacy of a dry alcoholic typhoid vaccine enriched with S. typhi Vi-antigen in the assessment of this vaccine in controlled epidemiological trial during the immunization of children aged 7--8 years. O- and Vi-antibodies were tested in the reaction of hemagglutination, H-antibodies--in the agglutination reaction with the microbial diagnostic agent, the properties of antibodies--in a test with cystein, and bactericidal properties of the sera--against the virulent S. typhi strain. Examination of 355 coupled sera obtained before and 3 weeks after the immunization demonstrated a high level of Vi-(1:47) and of the O-(1:580) antibodies and high bactericidal properties of the sera in persons vaccinated with the alcoholic vaccine enriched with the S. typhi Vi-antigen. The results obtained and the data on the formation of prolonged immunity following a simgle immunization suggested that a high protective effect was caused by a combined action of the O- and Vi-antigens contained in the vaccine in optimal doses.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000372 Agglutination Tests Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed) Agglutination Test,Test, Agglutination,Tests, Agglutination
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial

Related Publications

I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
October 1972, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
January 1969, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
February 2010, Journal of virology,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
February 1964, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
October 1962, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
March 1980, JPMA. The Journal of the Pakistan Medical Association,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
January 1965, Federation proceedings. Translation supplement; selected translations from medical-related science,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
January 1964, Przeglad epidemiologiczny,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
October 1988, Infection and immunity,
I L Kovalevskaia, and E S Shchelova, and Z N Ermolenko, and R A Braĭnina, and B Ia Shandalov
January 1972, Revista de investigacion en salud publica,
Copied contents to your clipboard!